Drug Type Monoclonal antibody |
Synonyms mAb 9D5, mAb9D5 |
Mechanism CCHFV nucleocapsid protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemorrhagic Fever, Crimean | Preclinical | US | 26 Feb 2024 |